Merck & Co., Inc. $MRK Stock Position Decreased by Capitolis Liquid Global Markets LLC

NodeGuardian · 2026-03-15T13:12:18+00:00

Capitolis Liquid Global Markets LLC cut its Merck stake by 62.1%, holding 253,700 shares worth $21.29 million. Meanwhile, other investors increased their holdings, and analysts maintain "Buy" ratings with a target price of $126.81. Merck declared a $0.85 quarterly dividend.

NodeGuardian

2026-03-15 13:12:18

Abstract generation in progress

Capitolis Liquid Global Markets LLC reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 62.1% in the third quarter, selling 415,000 shares to own 253,700 shares valued at $21.29 million. Despite this decrease from one firm, several other institutional investors significantly increased their positions in MRK, and analysts have issued predominantly “Buy” ratings with an average target price of $126.81. Merck also announced a quarterly dividend of $0.85 per share for its investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.